Recent News

By Category: Research

New state lab to test for bioterrorism agents

(The Republic) NEW ORLEANS — For the first time since Hurricane Katrina, south Louisiana will soon have a state laboratory that can test for anthrax, ricin and other bioterrorism threats. Stephen Martin, director of Louisiana's public health …

September 27, 2011
| Filed under North America, Agents & Toxins, Biosafety, and Research
Share

21st century vaccines — innovation in design and rational use

(Mary Ann Liebert, Inc./Genetic Engineering News) Innovation in the design of vaccines is rapidly expanding their use, safety, and effectiveness for disease prevention and therapeutic interventions. The enormous potential of OMICS sciences for global health and vaccine design is examined in “Vaccines of the 21st Century and Vaccinomics,” a special issue of OMICS: A Journal Read More »

September 26, 2011
| Filed under North America, Countermeasures, and Research
Share

Brazil Approves Biotech Dry Beans

(Truth about Trade & Technology) Brazil is the world's second largest producer of biotech crops and the Brazilian National Technical Commission on Biosafety has just approved a biotech dry bean for human consumption that is resistant to golden mosaic virus. …

September 23, 2011
| Filed under South America, Agriculture, Biotechnology, and Research
Share

Scientists work on new smallpox vaccine

(Newsday) Scientists work on new smallpox vaccine Published: September 19, 2011 7:03 PM By MOLLY PETERSON. Bloomberg News Smallpox, eradicated more than 30 years ago, is posing new challenges for federal regulators working to spur development of safer …and more »

September 20, 2011
| Filed under North America, Countermeasures, Public Health, and Research
Share

Japanese Smallpox Vaccine Shows Promise in US Testing – Global Security Newswire

Japanese Smallpox Vaccine Shows Promise in US TestingGlobal Security NewswireA decades-old smallpox vaccine created in Japan tested strongly in comparison with a licensed US treatment, the Center for Infectious Disease Research and Policy reported on Friday (see GSN, Jan. 14). The Japanese vaccine, LC16m8, contains a diluted …